Investigating the effects of antipsychotics on brain insulin action: Study protocol for a multi-modality magnetic resonance imaging (MRI) study in healthy controls
Antipsychotics (APs) are the cornerstone of treatment for schizophrenia (SCZ) but are unfortunately associated with serious metabolic adverse effects including weight gain and type 2 diabetes. The pathophysiology of AP-induced metabolic dysfunction is largely undetermined. Brain insulin resistance h...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2022-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704670/?tool=EBI |
| _version_ | 1811315660750323712 |
|---|---|
| author | Nicolette Stogios Laurie Hamel Emily Smith Marcos Sanches Gary Remington Aristotle Voineskos Satya Dash Ariel Graff-Guerrero Margaret Hahn Sri Mahavir Agarwal |
| author_facet | Nicolette Stogios Laurie Hamel Emily Smith Marcos Sanches Gary Remington Aristotle Voineskos Satya Dash Ariel Graff-Guerrero Margaret Hahn Sri Mahavir Agarwal |
| author_sort | Nicolette Stogios |
| collection | DOAJ |
| description | Antipsychotics (APs) are the cornerstone of treatment for schizophrenia (SCZ) but are unfortunately associated with serious metabolic adverse effects including weight gain and type 2 diabetes. The pathophysiology of AP-induced metabolic dysfunction is largely undetermined. Brain insulin resistance has been posited to be at the cross-roads of many cognitive and metabolic disorders, and disruption of central insulin action has emerged as a possible explanatory mechanism underlying AP induced metabolic dysfunction. Previous studies suggest that change in neuroimaging-based parameters with intranasal insulin administration can be leveraged to investigate brain insulin resistance. In this proof-of-concept study, we will utilize neural signatures of insulin action in the brain to examine if APs disrupt brain insulin signaling. It is hypothesized that: 1) intranasal insulin (INI), but not intranasal placebo (INP), will change cerebral blood flow and resting state connectivity, as well as increase glutamate levels in the striatum and dorsolateral prefrontal cortex; 2) oral olanzapine (OLA), but not oral placebo (PL), will inhibit the effect of INI on these parameters. Thirty-two healthy volunteers will undergo a single blind, cross-over design, wherein all participants receive the following four treatment combinations, 2–6 weeks apart, in a random sequence: INP + PL, INP + OLA, INI + PL, and INI + OLA. Participants will undergo an MRI-based assay of brain insulin resistance 15 minutes after administering 160 IU INI or INP. The scanning protocol includes resting and task-based functional MRI, arterial spin labelling, and proton magnetic resonance spectroscopy. Demonstrating that OLA can acutely induce brain insulin resistance is clinically relevant to metabolic health in SCZ. Evidence of brain insulin resistance induced by acute AP dosing can inform the early use of adjunctive insulin sensitizers for the treatment of metabolic comorbidities associated with AP treatment in severe mental illness. Trial registration ClinicalTrials.gov Registration: NCT03741478. |
| first_indexed | 2024-04-13T11:34:41Z |
| format | Article |
| id | doaj.art-f68d2fba4b5d4cf8b619a4f0e98baba7 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-04-13T11:34:41Z |
| publishDate | 2022-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-f68d2fba4b5d4cf8b619a4f0e98baba72022-12-22T02:48:28ZengPublic Library of Science (PLoS)PLoS ONE1932-62032022-01-011711Investigating the effects of antipsychotics on brain insulin action: Study protocol for a multi-modality magnetic resonance imaging (MRI) study in healthy controlsNicolette StogiosLaurie HamelEmily SmithMarcos SanchesGary RemingtonAristotle VoineskosSatya DashAriel Graff-GuerreroMargaret HahnSri Mahavir AgarwalAntipsychotics (APs) are the cornerstone of treatment for schizophrenia (SCZ) but are unfortunately associated with serious metabolic adverse effects including weight gain and type 2 diabetes. The pathophysiology of AP-induced metabolic dysfunction is largely undetermined. Brain insulin resistance has been posited to be at the cross-roads of many cognitive and metabolic disorders, and disruption of central insulin action has emerged as a possible explanatory mechanism underlying AP induced metabolic dysfunction. Previous studies suggest that change in neuroimaging-based parameters with intranasal insulin administration can be leveraged to investigate brain insulin resistance. In this proof-of-concept study, we will utilize neural signatures of insulin action in the brain to examine if APs disrupt brain insulin signaling. It is hypothesized that: 1) intranasal insulin (INI), but not intranasal placebo (INP), will change cerebral blood flow and resting state connectivity, as well as increase glutamate levels in the striatum and dorsolateral prefrontal cortex; 2) oral olanzapine (OLA), but not oral placebo (PL), will inhibit the effect of INI on these parameters. Thirty-two healthy volunteers will undergo a single blind, cross-over design, wherein all participants receive the following four treatment combinations, 2–6 weeks apart, in a random sequence: INP + PL, INP + OLA, INI + PL, and INI + OLA. Participants will undergo an MRI-based assay of brain insulin resistance 15 minutes after administering 160 IU INI or INP. The scanning protocol includes resting and task-based functional MRI, arterial spin labelling, and proton magnetic resonance spectroscopy. Demonstrating that OLA can acutely induce brain insulin resistance is clinically relevant to metabolic health in SCZ. Evidence of brain insulin resistance induced by acute AP dosing can inform the early use of adjunctive insulin sensitizers for the treatment of metabolic comorbidities associated with AP treatment in severe mental illness. Trial registration ClinicalTrials.gov Registration: NCT03741478.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704670/?tool=EBI |
| spellingShingle | Nicolette Stogios Laurie Hamel Emily Smith Marcos Sanches Gary Remington Aristotle Voineskos Satya Dash Ariel Graff-Guerrero Margaret Hahn Sri Mahavir Agarwal Investigating the effects of antipsychotics on brain insulin action: Study protocol for a multi-modality magnetic resonance imaging (MRI) study in healthy controls PLoS ONE |
| title | Investigating the effects of antipsychotics on brain insulin action: Study protocol for a multi-modality magnetic resonance imaging (MRI) study in healthy controls |
| title_full | Investigating the effects of antipsychotics on brain insulin action: Study protocol for a multi-modality magnetic resonance imaging (MRI) study in healthy controls |
| title_fullStr | Investigating the effects of antipsychotics on brain insulin action: Study protocol for a multi-modality magnetic resonance imaging (MRI) study in healthy controls |
| title_full_unstemmed | Investigating the effects of antipsychotics on brain insulin action: Study protocol for a multi-modality magnetic resonance imaging (MRI) study in healthy controls |
| title_short | Investigating the effects of antipsychotics on brain insulin action: Study protocol for a multi-modality magnetic resonance imaging (MRI) study in healthy controls |
| title_sort | investigating the effects of antipsychotics on brain insulin action study protocol for a multi modality magnetic resonance imaging mri study in healthy controls |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704670/?tool=EBI |
| work_keys_str_mv | AT nicolettestogios investigatingtheeffectsofantipsychoticsonbraininsulinactionstudyprotocolforamultimodalitymagneticresonanceimagingmristudyinhealthycontrols AT lauriehamel investigatingtheeffectsofantipsychoticsonbraininsulinactionstudyprotocolforamultimodalitymagneticresonanceimagingmristudyinhealthycontrols AT emilysmith investigatingtheeffectsofantipsychoticsonbraininsulinactionstudyprotocolforamultimodalitymagneticresonanceimagingmristudyinhealthycontrols AT marcossanches investigatingtheeffectsofantipsychoticsonbraininsulinactionstudyprotocolforamultimodalitymagneticresonanceimagingmristudyinhealthycontrols AT garyremington investigatingtheeffectsofantipsychoticsonbraininsulinactionstudyprotocolforamultimodalitymagneticresonanceimagingmristudyinhealthycontrols AT aristotlevoineskos investigatingtheeffectsofantipsychoticsonbraininsulinactionstudyprotocolforamultimodalitymagneticresonanceimagingmristudyinhealthycontrols AT satyadash investigatingtheeffectsofantipsychoticsonbraininsulinactionstudyprotocolforamultimodalitymagneticresonanceimagingmristudyinhealthycontrols AT arielgraffguerrero investigatingtheeffectsofantipsychoticsonbraininsulinactionstudyprotocolforamultimodalitymagneticresonanceimagingmristudyinhealthycontrols AT margarethahn investigatingtheeffectsofantipsychoticsonbraininsulinactionstudyprotocolforamultimodalitymagneticresonanceimagingmristudyinhealthycontrols AT srimahaviragarwal investigatingtheeffectsofantipsychoticsonbraininsulinactionstudyprotocolforamultimodalitymagneticresonanceimagingmristudyinhealthycontrols |